Quarterly report · Q2
4465.TEDINET S100SLRA
Period2023-06-01 → 2023-11-30
Filed2024-01-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.2bn | 2023-06-01 → 2023-11-30 | Cons. | Net sales |
| Revenue | ¥19.5bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.5bn | 2022-06-01 → 2022-11-30 | Cons. | Net sales |
| Operating income | ¥629m | 2023-06-01 → 2023-11-30 | Cons. | Operating income |
| Operating income | ¥605m | 2022-06-01 → 2022-11-30 | Cons. | Operating income |
| Ordinary income | ¥623m | 2023-06-01 → 2023-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥887m | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥616m | 2022-06-01 → 2022-11-30 | Cons. | Ordinary income |
| Profit before tax | −¥55m | 2023-06-01 → 2023-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥617m | 2022-06-01 → 2022-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥118m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥562m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥396m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥122m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss |
| Net income | ¥396m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss |
| Total assets | ¥23.6bn | at 2023-11-30 | Cons. | Assets |
| Total assets | ¥23.6bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥21.7bn | at 2022-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥10.6bn | at 2023-11-30 | Cons. | Liabilities |
| Total liabilities | ¥10.6bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥13.0bn | at 2023-11-30 | Cons. | Net assets |
| Net assets / equity | ¥13.0bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥12.9bn | at 2022-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.9bn | at 2023-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.7bn | at 2023-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.9bn | at 2023-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.7bn | at 2023-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.4bn | at 2022-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.1bn | at 2022-05-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥449m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥798m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥270m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥690m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥45m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥603m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥92m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥470m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥20.04 | 2023-06-01 → 2023-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.46 | 2023-09-01 → 2023-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥95.13 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.13 | 2022-06-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.45 | 2022-09-01 → 2022-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 54.7% | at 2023-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.6% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.5% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 15
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E00890-000Chemical Businessreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥10.5bn |
| jpcrp040300-q2r_E00890-000Chemical Businessreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥10.5bn |
| jpcrp040300-q2r_E00890-000Chemical Businessreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥579m |
| jpcrp040300-q2r_E00890-000Healthcare Businessreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥693m |
| jpcrp040300-q2r_E00890-000Healthcare Businessreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥693m |
| jpcrp040300-q2r_E00890-000Healthcare Businessreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥50m |
| —segment total | revenue | 2023-06-01 → 2023-11-30 | ¥11.2bn |
| —segment total | revenue external | 2023-06-01 → 2023-11-30 | ¥11.2bn |
| —segment total | segment profit | 2023-06-01 → 2023-11-30 | ¥629m |
| jpcrp040300-q2r_E00890-000Chemical Businessreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥9.5bn |
| jpcrp040300-q2r_E00890-000Chemical Businessreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥9.5bn |
| jpcrp040300-q2r_E00890-000Chemical Businessreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥605m |
| —segment total | revenue | 2022-06-01 → 2022-11-30 | ¥9.5bn |
| —segment total | revenue external | 2022-06-01 → 2022-11-30 | ¥9.5bn |
| —segment total | segment profit | 2022-06-01 → 2022-11-30 | ¥605m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 489
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -46816000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -90339000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -2410000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -1180000 | JPY |
| Proceeds from cancellation of insurance funds inv cf | Prior1YTDDuration | － | JPY |
| Proceeds from cancellation of insurance funds inv cf | CurrentYTDDuration | 360138000 | JPY |
| Collection of loans receivable inv cf | Prior1YTDDuration | 258000 | JPY |
| Collection of loans receivable inv cf | CurrentYTDDuration | 263000 | JPY |
| Other net inv cf | Prior1YTDDuration | 392000 | JPY |
| Other net inv cf | CurrentYTDDuration | 1920000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -44714000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | 269607000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -385114000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -406890000 | JPY |
| Redemption of bonds fin cf | Prior1YTDDuration | － | JPY |
| Redemption of bonds fin cf | CurrentYTDDuration | -5000000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -82648000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -188910000 | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | -1875000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -2016000 | JPY |
| Other net fin cf | Prior1YTDDuration | -47000 | JPY |
| Other net fin cf | CurrentYTDDuration | － | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -469685000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -602816000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 48123000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 45997000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 331722000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 162269000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 6057120000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 6745342000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 6388842000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 6907612000 | JPY |
| Employees salaries and bonuses sga | Prior1YTDDuration | 756288000 | JPY |
| Employees salaries and bonuses sga | CurrentYTDDuration | 867277000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 44422000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 49442000 | JPY |
| Freightage expenses sga | Prior1YTDDuration | 716307000 | JPY |
| Freightage expenses sga | CurrentYTDDuration | 751500000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00890-000ChemicalBusinessReportableSegmentsMember | 9537353000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 9537353000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 9537353000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00890-000ChemicalBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00890-000ChemicalBusinessReportableSegmentsMember | 9537353000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |